These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22878616)

  • 1. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.
    Spanheimer PM; Woodfield GW; Cyr AR; Kulak MV; White-Baer LS; Bair TB; Weigel RJ
    Ann Surg Oncol; 2013 Jul; 20(7):2204-12. PubMed ID: 22878616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
    De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
    Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
    Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
    Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
    Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
    Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
    Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
    Wang C; Mayer JA; Mazumdar A; Brown PH
    Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
    Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
    Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
    Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
    Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer.
    Spanheimer PM; Askeland RW; Kulak MV; Wu T; Weigel RJ
    J Surg Res; 2013 Sep; 184(1):519-25. PubMed ID: 23764310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.
    Lal G; Contreras PG; Kulak M; Woodfield G; Bair T; Domann FE; Weigel RJ
    PLoS One; 2013; 8(9):e73953. PubMed ID: 24023917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.
    Stine ZE; McGaughey DM; Bessling SL; Li S; McCallion AS
    Hum Mol Genet; 2011 Oct; 20(19):3746-56. PubMed ID: 21737465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFAP2C regulates carbonic anhydrase XII in human breast cancer.
    Franke CM; Gu VW; Grimm BG; Cassady VC; White JR; Weigel RJ; Kulak MV
    Oncogene; 2020 Feb; 39(6):1290-1301. PubMed ID: 31636386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
    Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
    Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A
    Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
    Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
    Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
    Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
    Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
    Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
    Horibata S; Rice EJ; Mukai C; Marks BA; Sams K; Zheng H; Anguish LJ; Coonrod SA; Danko CG
    PLoS One; 2018; 13(4):e0194023. PubMed ID: 29608602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer.
    Kakati RT; Kim H; Whitman A; Spanheimer PM
    Breast Cancer Res Treat; 2023 Jun; 199(3):589-601. PubMed ID: 37061618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.